Fig. 3: HRD, TMB and CNV burden according to number of fusions in breast cancer.
From: Prognostic value of structural variants in early breast cancer patients
a Homologous recombinant deficiency (HRD) score, b Tumoral mutational burden (TMB). c Copy number variant (CNV burden) between high (n = 45) and low (n = 81) number of fusions in all breast cancer (BC) (n = 126 which being performed both WTS and whole exome sequencing), d HRD score, e TMB. f CNV burden between high (n = 10) and low (n = 23) number of fusions in HR + HER2- BC, g HRD score. h TMB. i CNV burden between high (n = 7) and low (n = 16) number of fusions in HR + HER2 + BC. j HRD score. k TMB, l CNV burden between high (n = 8) and low (n = 8) number of fusions in HR-HER2 + BC. m HRD score. n TMB. o CNV burden between high (n = 20) and low (n = 34) number of fusions in TNBC.
